Noel Pin-Vieito

Dr. Noel Pin-Vieito

Complexo Hospitalario Universitario Ourense
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
EAEduardo Albéniz
Eduardo Albéniz
MFMaría Fraile
María Fraile
BIBerta Ibañez-Beroiz
Berta Ibañez-Beroiz
PAPedro Alonso-Aguirre
Pedro Alonso-Aguirre
DMDavid Martínez-Ares
David Martínez-Ares
CGCarlos Guarner-Argente
Carlos Guarner-Argente

21 May 2019 in World Journal of Gastroenterology
Verified
Journal Article
Open access
Noel Pin-VieitoNoel Pin-Vieito
Noel Pin-Vieito
SZSara Zarraquiños
Sara Zarraquiños
Joaquin CubiellaJoaquin Cubiella
Joaquin Cubiella
The quantitative faecal immunochemical test for haemoglobin (FIT) has been revealed to be highly accurate for colorectal cancer (CRC) detection not only in a screening setting, but also in the assessment of patients presenting lower bowel symptoms. Therefore, the National Institute for Health and Care Excellence has recommended the adoption of FIT in primary care to guide referral for suspected CRC in low-risk symptomatic patients using a 10 µg Hb/g faeces threshold. Nevertheless, it is unknown whether FIT´s accuracy remains stable throughout the broad spectrum of possible symptoms. To perform a systematic review and meta-analysis to assess FIT accuracy for CRC detection in different clinical settings. A systematic literature search was performed using MEDLINE and EMBASE databases from inception to May 2018 to conduct a meta-analysis of prospective studies including symptomatic patients that evaluated the diagnostic accuracy of quantitative FIT for CRC detection. Studies were classified on the basis of brand, threshold of faecal haemoglobin concentration for a positive test result, percentage of reported symptoms (solely symptomatic, mixed cohorts) and CRC prevalence (< 2.5%, ≥ 2.5%) to limit heterogeneity and perform subgroup analysis to assess the influence of clinical spectrum on FIT´s accuracy to detect CRC. Fifteen cohorts including 13073 patients (CRC prevalence 0.4% to 16.8%) were identified. Pooled estimates of sensitivity for studies using OC-Sensor at 10 µg Hb/g faeces threshold (n = 10400) was 89.6% [95% confidence interval (CI): 82.7% to 94.0%). However, pooled estimates of sensitivity for studies formed solely by symptomatic patients (n = 4035) and mixed cohorts (n = 6365) were 94.1% (95%CI: 90.0% to 96.6%) and 85.5% (95%CI: 76.5% to 91.4%) respectively (P < 0.01), while there were no statistically significant differences between pooled sensitivity of studies with CRC prevalence < 2.5% (84.9%, 95%CI: 73.4% to 92.0%) and ≥ 2.5% (91.7%, 95%CI: 83.3% to 96.1%) (P = 0.25). At the same threshold, OC-Sensor® sensitivity to rule out any significant colonic lesion was 78.6% (95%CI: 75.6% to 81.4%). We found substantial heterogeneity especially when assessing specificity. The results of this meta-analysis confirm that, regardless of CRC prevalence, quantitative FIT is highly sensitive for CRC detection. However, FIT ability to rule out CRC is higher in studies solely including symptomatic patients.

9 June 2021 in Gut
Verified
Journal Article
Closed access
PDF file
Noel Pin-VieitoNoel Pin-Vieito
Noel Pin-Vieito
CTCoral Tejido-Sandoval
Coral Tejido-Sandoval
NVNatalia de Vicente-Bielza
Natalia de Vicente-Bielza
CSCristina Sánchez-Gómez
Cristina Sánchez-Gómez
Joaquin CubiellaJoaquin Cubiella
Joaquin Cubiella
Objective Implementation of faecal immunochemical tests (FIT) as a triage test in primary healthcare may improve the efficiency of referrals without missing cases of colorectal cancer (CRC). We aim to summarise the performance characteristics of FITs for CRC in symptomatic patients presenting to primary healthcare. Design We performed a systematic literature review of Medline and EMBASE databases from May 2018 to November 2020. Previous related systematic searches were also adapted to this aim and completed with reference screening. We identified studies performed on adult patients consulting for abdominal symptoms in primary care which reported data such that the FIT diagnostic performance parameters for CRC could be obtained. Bivariate models were used to synthesise available evidence. Meta-regression analysis was performed to evaluate the causes of heterogeneity. Results Twenty-three studies (69 536 participants) were included (CRC prevalence 0.3%–6.2%). Six studies (n=34 691) assessed FIT as rule in test (threshold of ≥150 µg Hb/g faeces) showing a sensitivity of 64.1% (95% CI 57.8% to 69.9%) and a specificity of 95.0% (95% CI 91.2% to 97.2%). A threshold of 10 µg/g (15 studies; n=48 872) resulted in a sensitivity of 87.2% (95% CI 81.0% to 91.6%) and a specificity of 84.4% (95% CI 79.4% to 88.3%) for CRC. At a 20 µg Hb/g faeces threshold (five studies; n=24 187) less than one additional CRC would be missed per 1000 patients investigated compared with 10 µg Hb/g faeces threshold (CRC prevalence 2%). Conclusion FIT is the test of choice to evaluate patients with new-onset lower gastrointestinal symptoms in primary healthcare.

15 September 2001 in Cancer
Verified
Journal Article
Closed access
PDF file
CRCarlos Rodriguez-Galindo
Carlos Rodriguez-Galindo
DHD. Ashley Hill
D. Ashley Hill
OOOnynye Onyekwere
Onynye Onyekwere
Noel Pin-VieitoNoel Pin-Vieito
Noel Pin-Vieito
BRBhaskar N. Rao
Bhaskar N. Rao
VSVictor M. Santana
Victor M. Santana

1 March 2021 in United European Gastroenterology Journal
Verified
Journal Article
Open access
PDF file
Noel Pin-VieitoNoel Pin-Vieito
Noel Pin-Vieito
LNLaura García Nimo
Laura García Nimo
LBLuis Bujanda
Luis Bujanda
BABegona Román Alonso
Begona Román Alonso
MGMaría Ángeles Gutierrez‐Stampa
María Ángeles Gutierrez‐Stampa
Joaquin CubiellaJoaquin Cubiella
Joaquin Cubiella
Background: Optimizing colonoscopy resources is challenging, and information regarding performing diagnostic quantitative faecal immunochemical test (FIT) in daily clinical practice in primary health care is still limited. This study aimed to assess the sensitivity, specificity, positive predictive value and negative predictive value of varying FIT positivity thresholds on colorectal cancer (CRC) detection in primary health care.Methods: A retrospective cohort study of 38,675 asymptomatic and symptomatic patients with a FIT (OC‐Sensor™) performed between 2012 and 2016 in a primary health‐care setting, using a clinical laboratory database of two Spanish areas linked with the National Health System's Hospital Discharge Records Database. The primary outcome was 2‐year CRC incidence.Results: The mean age of the participants was 63.2 years; 17,792 (46.0%) were male. CRC prevalence was 1.7% (650/38,675). The percentage of patients with a FIT result above the threshold was 20.7% and 14.6% for 10 μg Hb/g faeces and 20 μg Hb/g faeces thresholds, respectively. Sensitivity was 90.5% (95% confidence interval 88.0%–92.5%) at a 10 μg Hb/g faeces threshold, and this decreased by 3.1% when a 20 μg Hb/g faeces threshold was used. The negative predictive value for CRC was at least 99.2% in any subgroup analysed. At a 20 μg Hb/g faeces threshold, less than one additional CRC would be missed per 1000 patients investigated, while approximately 1.3 times more colonoscopy examinations were needed to identify an incidence of CRC using the lowest threshold for any situation analysed.Conclusions: In primary health care, a quantitative FIT threshold should be tailored to colonoscopy capacity and CRC prevalence in specific populations.

1 November 2019 in Gastroenterología y Hepatología
Verified
Journal Article
Closed access
JCJesús Daniel Fernández-De Castro
Jesús Daniel Fernández-De Castro
FUFranco Baiocchi Ureta
Franco Baiocchi Ureta
RGRaquel Fernández González
Raquel Fernández González
Noel Pin-VieitoNoel Pin-Vieito
Noel Pin-Vieito
Joaquin CubiellaJoaquin Cubiella
Joaquin Cubiella